These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 24588457)

  • 1. Gaucher disease: haematological presentations and complications.
    Thomas AS; Mehta A; Hughes DA
    Br J Haematol; 2014 May; 165(4):427-40. PubMed ID: 24588457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gaucher's disease ].
    Belmatoug N; Caubel I; Stirnemann J; Billette de Villemeur T
    J Soc Biol; 2002; 196(2):141-9. PubMed ID: 12360743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
    Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
    Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaucher disease: unmet treatment needs.
    Mehta A
    Acta Paediatr; 2008 Apr; 97(457):83-7. PubMed ID: 18339195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaucher disease: a lysosomal neurodegenerative disorder.
    Huang WJ; Zhang X; Chen WW
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1219-26. PubMed ID: 25912581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP
    Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.
    Yang NY; Lee YN; Lee HJ; Kim YS; Lee SJ
    Biol Chem; 2013 Jul; 394(7):807-18. PubMed ID: 23435096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of the neurological forms of Gaucher's disease].
    Capablo Liesa JL; de Cabezón AS; Alarcia Alejos R; Ara Callizo JR
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():6-11. PubMed ID: 22230119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher disease: multiple lessons from a single gene disorder.
    Beutler E
    Acta Paediatr Suppl; 2006 Apr; 95(451):103-9. PubMed ID: 16720474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gaucher disease: A review].
    Nguyen Y; Stirnemann J; Belmatoug N
    Rev Med Interne; 2019 May; 40(5):313-322. PubMed ID: 30638965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone.
    Mikosch P
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):665-81. PubMed ID: 22142746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hematological aspects of Gaucher disease].
    Costello R; O'Callaghan T; Baccini V; Sébahoun G
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S176-9. PubMed ID: 18228684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
    Ceravolo F; Grisolia M; Sestito S; Falvo F; Moricca MT; Concolino D
    J Med Case Rep; 2017 Jan; 11(1):19. PubMed ID: 28103924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.
    Velayati A; Yu WH; Sidransky E
    Curr Neurol Neurosci Rep; 2010 May; 10(3):190-8. PubMed ID: 20425034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate reduction therapy of glycosphingolipid storage disorders.
    Aerts JM; Hollak CE; Boot RG; Groener JE; Maas M
    J Inherit Metab Dis; 2006; 29(2-3):449-56. PubMed ID: 16763917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematological manifestations and complications of Gaucher disease.
    Linari S; Castaman G
    Expert Rev Hematol; 2016 Jan; 9(1):51-8. PubMed ID: 26565753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercoagulability, parkinsonism, and Gaucher disease.
    Rosenbaum H; Aharon-Peretz J; Brenner B
    Semin Thromb Hemost; 2013 Nov; 39(8):928-34. PubMed ID: 24129683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher Disease for Hematologists.
    Özdemir GN; Gündüz E
    Turk J Haematol; 2022 Jun; 39(2):136-139. PubMed ID: 35439918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.